CRP and neoplasm: As shown in Table 4, in univariable analysis, median OS was significantly correlated with ECOG performance score (2 vs 0-1, 1.1 vs 27.7 months, p=0.005), stage (III-IVa vs II, 22.1 months vs not reached [NR], p=0.014), pre-treatment GTV volume (≥60.5 vs <60.5 cm3, 16.5 months vs NR, p=0.004), baseline NRI (≥105.2 vs <105.2, 16.5 months vs NR, p=0.036), baseline CRP level (≥10 vs <10mg/L, 13.5 months vs NR, p=0.003) and tumor response (non-CR vs CR, 13.5 months vs NR, p=0.000).